226 related articles for article (PubMed ID: 15133855)
1. Overexpression of annexin 1 in pancreatic cancer and its clinical significance.
Bai XF; Ni XG; Zhao P; Liu SM; Wang HX; Guo B; Zhou LP; Liu F; Zhang JS; Wang K; Xie YQ; Shao YF; Zhao XH
World J Gastroenterol; 2004 May; 10(10):1466-70. PubMed ID: 15133855
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma.
Chen CY; Shen JQ; Wang F; Wan R; Wang XP
Asian Pac J Cancer Prev; 2012; 13(9):4707-12. PubMed ID: 23167407
[TBL] [Abstract][Full Text] [Related]
3. Annexin A2 and CD105 expression in pancreatic ductal adenocarcinoma is associated with tumor recurrence and prognosis.
Huang YK; Liu H; Wang XZ; Zhu S
Asian Pac J Cancer Prev; 2014; 15(22):9921-6. PubMed ID: 25520129
[TBL] [Abstract][Full Text] [Related]
4. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
[TBL] [Abstract][Full Text] [Related]
5. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
6. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
Karanjawala ZE; Illei PB; Ashfaq R; Infante JR; Murphy K; Pandey A; Schulick R; Winter J; Sharma R; Maitra A; Goggins M; Hruban RH
Am J Surg Pathol; 2008 Feb; 32(2):188-96. PubMed ID: 18223320
[TBL] [Abstract][Full Text] [Related]
7. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
9. Gli1 expression in pancreatic ductal adenocarcinoma and its clinical significance.
Abula Y; Yi C; Wang XY; Wang M; Qin RY; Guo YQ; Lin H; Li HJ
Genet Mol Res; 2015 Oct; 14(4):12323-9. PubMed ID: 26505381
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
[TBL] [Abstract][Full Text] [Related]
11. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Byers JT; Paniccia A; Kaplan J; Koenig M; Kahn N; Wilson L; Chen L; Schulick RD; Edil BH; Zhu Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1574-9. PubMed ID: 25519928
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma.
Kang WY; Chen WT; Huang YC; Su YC; Chai CY
Kaohsiung J Med Sci; 2012 Mar; 28(3):145-50. PubMed ID: 22385607
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
15. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY
Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
17. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
18. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
19. Association of chloride intracellular channel 4 and Indian hedgehog proteins with survival of patients with pancreatic ductal adenocarcinoma.
Zou Q; Yang Z; Li D; Liu Z; Yuan Y
Int J Exp Pathol; 2016 Dec; 97(6):422-429. PubMed ID: 28205343
[TBL] [Abstract][Full Text] [Related]
20. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]